Publication Archive: Opioids Litigation

J&J, Teva offer a massive $48B combined to wrap opioid suits, but not all plaintiffs are on board With reports like that in the ether, it’s no wonder some plaintiffs are reticent to sign on to the “framework deal” that includes the Teva and J&J offers, along with additional deals with three drug distributors. Officials in at least four…Read the article

In interviews with Reuters, lawyers representing local governments in the opioid litigation said the figure proposed by Teva inflates the real value of the drugs. They said the proposal will not be enough to address a nationwide addiction crisis that has claimed some 400,000 lives over the last two decades. The deal is “overvalued to…Read the article

While the nation’s first federal opioid trial ended Monday without an actual trial, the cases drug companies face nationwide are far from over. Attorneys representing the thousands cities and counties in federal court said they intend to pursue their other cases and that negotiations should continue. After talks broke down on Friday with state attorneys…Read the article

The deal settles claims brought by Ohio’s Cuya hoga and Summit counties, which had accused the companies of fuelling a nationwide opioid crisis. Some 400,000 US overdose deaths between 1997 and 2017 were linked to opioids, ac cording to government data. The trial was to be a so-called bellwether, or test trial, that was meant…Read the article

The nation’s three biggest drug distributors and a major drugmaker agreed to an eleventh-hour, $260 million settlement Monday over the terrible toll taken by opioids in two Ohio counties, averting the first federal trial over the crisis. Across the U.S., the pharmaceutical industry still faces more than 2,600 other lawsuits over the deadly disaster. Participants…Read the article

Nationwide, the pharmaceutical industry still faces more than 2,600 other lawsuits over the ongoing opioid abuse epidemic. Participants in those cases said the Ohio deal buys them time to try to work out a nationwide settlement of all claims, the AP said. “People can’t lose sight of the fact that the counties got a very…Read the article

An Indiana awsuit was filed one day after a tentative settlement was reached in an Ohio lawsuit that was viewed as a harbinger for legal claims filed by more than 2,700 local and state governments. McKesson Corp., Cardinal Health Inc., AmerisourceBergen Corp. — which are also the defendants in the Indiana lawsuit — and drug-maker Teva Pharmaceutical Industries Ltd. will pay a…Read the article

Four drug companies have reached a settlement with two northeast Ohio counties to avoid a trial claiming their responsibility for the opioid epidemic. What’s next The settlement does not include the fifth defendant, Walgreens, the drugstore chain who was sued over its own distribution operation. Attorneys for the plaintiffs said Walgreens would be included in…Read the article

What drugs does Teva make?  It specializes primarily in generic drugs. Some of the opioid drugs include oxycodone and fentanyl, which is a synthetic opiate. Another is oxymorphone. Terms of a deal involving McKesson Corp., Cardinal Health Inc., AmerisourceBergen Corp. and Teva Pharmaceutical Industries Ltd. were expected to be announced later in the day. Cuyahoga County lawyer…Read the article

Drug distributors AmerisourceBergen, Cardnial Health and McKesson will pay a combined $215 million, said Hunter Shkolnik, a lawyer for Cuyahoga County. Israeli-based drugmaker Teva will contribute $20 million in cash and $25 million worth of generic Suboxone, a drug used to treat opioid addiction.Read the article